Atara Biotherapeutics, Inc. (ATRA) Earnings Signals & AI Vibe Check
Cross-checked across multiple AI analysts and grounded in the latest SEC filing.
powered by: earningsVibe.ai
Question:
What is the latest filing signal for Atara Biotherapeutics, Inc.?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest
10-K, Atara Biotherapeutics, Inc.'s filing signal
turned negative.
earningsVibe SuperAnalyst™ Verdict:
TURNED NEGATIVE
Signal Performance — Stock Price Since Filing
30-Day Change
Pending
from filing date
60-Day Change
Pending
from filing date
Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT
PERPLEXITY
Continuing Negative
GEMINI
Turned Negative
CLAUDE
Turned Positive
CHATGPT
Turned Negative
Unlock the Full Filing Analysis
See full earningsSig™ and risksSig™ analysis across 5,000+ companies
Get Started Free →No credit card required
Question:
What does Atara Biotherapeutics, Inc. actually do?
Answer:
Atara Biotherapeutics is a leader in T-cell immunotherapy, developing transformative therapies for cancer and autoimmune diseases using its allogeneic Epstein-Barr virus (EBV) T-cell platform. Its lead product, tab-cel (Ebvallo), has received marketing authorization in the European Economic Area, the United Kingdom, and Switzerland for EBV+ PTLD. The company has partnered with Pierre Fabre for worldwide commercialization of tab-cel, which is currently in Phase 3 development in the U.S. Atara has also paused development of its CAR T cell programs (ATA3219 and ATA3431) and discontinued development of ATA188 for multiple sclerosis. The company's allogeneic, off-the-shelf T-cell platform allows for rapid delivery of manufactured cells, differentiating it from autologous treatments.
Question:
What are Atara Biotherapeutics, Inc.'s revenue drivers?
Answer:
Revenue is primarily driven by commercialization agreements, including upfront fees, milestone payments, and royalties from its partner Pierre Fabre for Ebvallo (tab-cel).
Cut through noisy SEC filings to find the signal faster
Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.
Get Started Free →No credit card required